Setting a new standard for the future of pharma
Who we are
Alvogen is a privately owned US-based company focused on developing, in-licensing, manufacturing and marketing pharmaceutical products.
Alvogen's companies include:
Alvogen generic business
Almatica brand products
Almaject injectables
Norwich US-based manufacturing
Targeted portfolio
Alvogen is growing its portfolio of complex, high value products including complex inhalation, injectables and strategic 505(b)(2) products.
Alvogen has over 50 products currently on market and extensive R&D capabilities fueling its growing pipeline.
Meet our Chairman
Róbert founded Alvogen in 2009, serving as CEO until 2022, and continues as chairman today. Having sketched the business plan on a restaurant napkin, he assembled the investors to buy and revive a struggling US drug manufacturer as the core of the company.
Making a difference
Our true purpose as a company is to make people's lives better by producing high quality medicines that help people live longer, healthier and more active lives and making them more accessible to those who might not otherwise be able to afford them.
Open for collaboration
At Alvogen, we value partnerships and collaboration. Our future strategy relies heavily on our strategic selection of people and successful partnerships around the world.
